drugset / Trial / NCT02407912
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the effect and toxicity of intrapleural administration of hypertonic cisplatin for malignant pleural effusion in patients with non-small-cell lung cancer.
Timeline
- Start
- 2015-03
- Primary completion
- 2018-03
- Completion
- 2020-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | Other |